FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective

Cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

Ting‐Chao Chou · Cancer Research · 2010 · 5.7K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

Medicine, Oncology, Pharmacology +15

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding, Gad Getz, David A. Wheeler et al. · Nature · 2008 · 2.7K citations · Full text

Medicine, Genetics, Oncology +16

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · JNCI Journal of the National Cancer Institute · 2005 · 2.1K citations · Full text

Medicine, Biostatistics, Oncology +16